Pasithea Therapeutics (KTTA) Profit After Tax (2021 - 2024)
Historic Profit After Tax for Pasithea Therapeutics (KTTA) over the last 4 years, with Q4 2024 value amounting to -$3.2 million.
- Pasithea Therapeutics' Profit After Tax rose 3705.31% to -$3.2 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$13.9 million, marking a year-over-year increase of 1288.76%. This contributed to the annual value of -$13.9 million for FY2024, which is 1288.76% up from last year.
- According to the latest figures from Q4 2024, Pasithea Therapeutics' Profit After Tax is -$3.2 million, which was up 3705.31% from -$3.0 million recorded in Q3 2024.
- In the past 5 years, Pasithea Therapeutics' Profit After Tax registered a high of $630143.0 during Q4 2021, and its lowest value of -$5.1 million during Q4 2022.
- In the last 4 years, Pasithea Therapeutics' Profit After Tax had a median value of -$3.4 million in 2023 and averaged -$2.9 million.
- Per our database at Business Quant, Pasithea Therapeutics' Profit After Tax plummeted by 91214.71% in 2022 and then surged by 3705.31% in 2024.
- Pasithea Therapeutics' Profit After Tax (Quarter) stood at $630143.0 in 2021, then tumbled by 912.15% to -$5.1 million in 2022, then grew by 1.36% to -$5.0 million in 2023, then soared by 37.05% to -$3.2 million in 2024.
- Its Profit After Tax stands at -$3.2 million for Q4 2024, versus -$3.0 million for Q3 2024 and -$3.9 million for Q2 2024.